Polyethylene Wear Study on the Triathlon Total Knee Prosthesis
X3vsN2Vac
1 other identifier
interventional
100
1 country
1
Brief Summary
Comparison of conventional UHMWPE (ultra-high-molecular-weight polyethylene) with highly cross-linked polyethylene (X3) in a condylar stabilizing (CS) fixed bearing total knee prosthesis by means of RSA and clinical evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 11, 2015
CompletedFirst Posted
Study publicly available on registry
August 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2019
CompletedResults Posted
Study results publicly available
April 7, 2020
CompletedFebruary 22, 2024
February 1, 2024
7.6 years
June 11, 2015
March 12, 2020
February 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of Polyethylene Inlay Wear by Roentgen Stereophotogrammetric Analysis (RSA).
RSA is a highly accurate technique for the assessment of three-dimensional migration and micro motion of a joint replacement prosthesis relative to the bone it is attached to. Because of the high accuracy, RSA can also be used to measure wear in knee replacements and is used in this study for the assessment of the wear of the two polyethylene inlay types N2Vac polyethylene and X3 polyethylene.
1, 2 and 5 years follow-up
Secondary Outcomes (5)
Assessment of Prosthetic Migration Results After Two Years by RSA.
3 and 6 months,1, 2 and 5 years follow-up
Investigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)
Pre-operative, 6 weeks, 3 and 6 months, 1, 2 and 5 years
Investigation of Clinical Performance and Patient Outcome With the Short Form Patient Questionnaire (SF-36)
Pre-operative, 6 weeks, 3 and 6 months, 1, 2 and 5 years
Investigation of Clinical Performance and Patient Outcome With the EuroQuol - 5 Dimension (EQ-5D) Patient Questionnaire
Pre-operative, 6 weeks, 3 and 6 months, 1, 2 and 5 years
Investigation of Clinical Performance and Patient Outcome With the Lower Extremity Activity Scale (LEAS) Patient Questionnaire
Pre-operative, 6 weeks, 3 and 6 months, 1, 2 and 5 years
Study Arms (2)
Conventional polyethylene inlay nitrogen/vacuum-packed (N2Vac)
ACTIVE COMPARATORConventional UHMWPE inlay in a Triathlon Condyle Stabilizing (CS) fixed bearing total knee prosthesis
Highly cross-linked polyethylene (X3)
ACTIVE COMPARATORX3 highly cross-linked polyethylene inlay in a Triathlon CS fixed bearing total knee prosthesis
Interventions
The patient will receive either the N2Vac polyethylene inlay or the X3 polyethylene inlay for their CS total knee.
Eligibility Criteria
You may qualify if:
- Patient is able to understand the meaning of the study and is willing to sign the Ethic Commission approved, study specific Informed Patient Consent Form.
- Patients with a pre-operative knee score of \< 70.
- Patients scheduled to undergo primary total knee replacement with any of the following indication.
- Painful and disabled knee joint resulting from osteoarthritis.
- One or more compartments are involved.
- Need to obtain pain relief and improve function.
- Ability and willingness to follow instructions, including control of weight and activity level, and to return for follow-up evaluations.
- A good nutritional state of the patient.
- Full skeletal maturity of the patient, patients who are at least 18 years of age.
- Patients of either sex.
You may not qualify if:
- The subject is morbidly obese, defined as Body Mass Index (BMI) of \> 40.
- Skeletal immaturity of the patient, patients who are less than 18 years of age.
- Patient has a flexion contracture of 15° and more.
- Patient has a varus/valgus contracture of 15° and more.
- Patients with a pre-operative knee score of \>70.
- The subject has a history of total or unicompartmental reconstruction of the affected joint.
- The subject will be operated bilaterally.
- Patients who had a Total Hip Arthroplasty (THA) on contralateral and/or ipsilateral side within the last year that is considered to have an unsatisfactory outcome (Patients with contralateral and/or ipsilateral THA \> 1 year ago with good outcome can be included in the study).
- Patients who had a Total Knee Arthroplasty (TKA) on contralateral side within the last 6 months that is considered to have an unsatisfactory outcome. (Patients with contralateral TKA \> 6 months ago with good outcome can be included in the study).
- The subject has an active or suspected latent infection in or about the knee joint.
- Osteomyelitis.
- Sepsis.
- Patients who will need lower limb joint replacement for another joint within one year.
- The subject has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
- The subject has a systemic or metabolic disorder leading to progressive bone deterioration.
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Orthopaedics 't Langeland Ziekenhuis Zoetermeer
Zoetermeer, South Holland, 2725 NA, Netherlands
Results Point of Contact
- Title
- Britta von den Brincken, Clinical Study Manager
- Organization
- Stryker
Study Officials
- PRINCIPAL INVESTIGATOR
H. Kaptijn, MD
't Langeland Ziekenhuis Zoetermeer
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2015
First Posted
August 17, 2015
Study Start
September 1, 2011
Primary Completion
March 28, 2019
Study Completion
March 28, 2019
Last Updated
February 22, 2024
Results First Posted
April 7, 2020
Record last verified: 2024-02